FCE-28718

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameFCE-28718
Drug Alias NameFCE-28718
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockersAromatase inhibitors
TargetsAromataseVoltage-gated calcium channel
Therapy Area/IndicationsEndometriosisProstatic HyperplasiaInfertility +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacia & Upjohn Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacia & Upjohn Spa
Active IndicationsN/A
Inactive IndicationsEndometriosisProstatic HyperplasiaInfertility +[6] 

Other Information

ATC CodeN/A
Related LinksN/A